Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
June 29, 2022 | 62.02 |
June 28, 2022 | 61.07 |
June 27, 2022 | 64.37 |
June 24, 2022 | 61.80 |
June 23, 2022 | 61.97 |
June 22, 2022 | 54.40 |
June 21, 2022 | 49.48 |
June 17, 2022 | 48.13 |
June 16, 2022 | 45.05 |
June 15, 2022 | 49.32 |
June 14, 2022 | 46.30 |
June 13, 2022 | 43.39 |
June 10, 2022 | 48.59 |
June 09, 2022 | 49.61 |
June 08, 2022 | 59.94 |
June 07, 2022 | 56.86 |
June 06, 2022 | 56.86 |
June 03, 2022 | 53.54 |
June 02, 2022 | 66.95 |
June 01, 2022 | 64.16 |
May 31, 2022 | 66.18 |
May 27, 2022 | 66.13 |
May 26, 2022 | 56.30 |
May 25, 2022 | 55.18 |
May 24, 2022 | 55.67 |
Date | Value |
---|---|
May 23, 2022 | 61.48 |
May 20, 2022 | 63.90 |
May 19, 2022 | 69.89 |
May 18, 2022 | 62.33 |
May 17, 2022 | 62.14 |
May 16, 2022 | 57.41 |
May 13, 2022 | 62.07 |
May 12, 2022 | 57.39 |
May 11, 2022 | 51.34 |
May 10, 2022 | 64.42 |
May 09, 2022 | 63.70 |
May 06, 2022 | 68.54 |
May 05, 2022 | 70.16 |
May 04, 2022 | 75.03 |
May 03, 2022 | 70.44 |
May 02, 2022 | 64.29 |
April 29, 2022 | 53.91 |
April 28, 2022 | 52.95 |
April 27, 2022 | 55.57 |
April 26, 2022 | 56.72 |
April 25, 2022 | 60.05 |
April 22, 2022 | 55.79 |
April 21, 2022 | 58.37 |
April 20, 2022 | 64.21 |
April 19, 2022 | 65.29 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
8.628
Minimum
May 13 2021
90.04
Maximum
Apr 04 2022
36.04
Average
29.41
Median
Price to Book Value Benchmarks
Pfizer Inc | 1.815 |
Moderna Inc | 1.793 |
BioCryst Pharmaceuticals Inc | -- |
Eli Lilly and Co | 54.59 |
AIM ImmunoTech Inc | 2.710 |
Price to Book Value Related Metrics
PS Ratio | 1.588 |
Price | 9.35 |
Earnings Yield | -29.84% |
Market Cap | 1.497B |